Centrus Energy is the only American company licensed to produce the high-assay nuclear fuel needed for next-generation reactors, making it a critical asset for the future of domestic energy. The company brought in $450 million in revenue last year while building a $3.8 billion backlog of contracts that stretches out to the year 2040. As the United States aggressively moves to end its reliance on Russian uranium, Centrus occupies the narrow bottleneck between old fuel supplies and the next wave of small modular reactors.
The investment thesis on Centrus Energy is that its unique regulatory status as the sole domestic enricher of high-assay low-enriched uranium (HALEU) creates a government-backed monopoly on the future of nuclear power. While the company spent years acting as a middleman for Russian fuel, it is now pivoting toward its own production at its facility in Piketon, Ohio. If Centrus can scale its own enrichment capacity while securing the government funding needed to replace Russian supply, it will own the primary spigot for the next generation of carbon-free energy.
We think Centrus is a vital national asset but the stock has run far ahead of its underlying business value, pricing in years of perfect execution before the first commercial cascades are even fully built. While the strategic importance of the business is undeniable, the current valuation assumes massive growth that is not yet visible in the financial results. One stumble in government funding or a delay in scaling production would be enough to break the case.
Centrus Energy stock soared over the past few years before dropping back down recently. The price climbed sharply because the company is the only one in the United States licensed to make fuel for next-generation nuclear reactors. It has cooled off lately as investors wait to see if the company can turn its long-term contracts into steady profits.
Sign up free to unlock current fair value, 5 year price projections, and our final verdict.
What does it do?
Centrus Energy earns money by selling nuclear fuel and enrichment services to utilities and government agencies through its specialized production facilities. The core business revolves around "SWU" (Separative Work Units), which is essentially the effort required to enrich uranium into fuel for power plants. Centrus historically acted as a high-margin middleman, buying fuel from Russia and selling it globally, but it is now using its NRC-licensed facility in Ohio to become a primary manufacturer. Customers sign multi-year, multi-billion-dollar contracts that provide predictable revenue once delivery begins.
Where does revenue come from?
The vast majority of revenue comes from the LEU segment, which provides low-enriched uranium to fuel existing nuclear power plants. This segment accounted for $51.3 million of the $73.1 million in revenue in the first quarter of 2025. The Technical Solutions segment brings in the remainder by providing engineering and enrichment services under contract, primarily to the U.S. Department of Energy. Geographically, Centrus serves a global market including the United States, Japan, and Belgium.
Revenue Breakdown
Revenue by Geography
Who are its customers?
Centrus Energy serves a concentrated group of approximately 30 utility companies that operate nuclear power plants globally, alongside the U.S. Department of Energy. Because the nuclear fuel market is highly regulated, the customer base is small but extremely stable, with the company currently holding a total backlog of $3.8 billion. In the first quarter of 2025, SWU revenue increased as the average price of fuel sold jumped 46% and the volume sold rose by 49%. The company's future depends on a new customer type: the developers of next-generation reactors who require HALEU fuel that only Centrus is currently licensed to produce in America.
What gives it staying power?
Centrus holds the only license from the Nuclear Regulatory Commission to enrich uranium to the higher levels needed for advanced reactors. This creates a massive regulatory barrier to entry that no startup can easily replicate. The $3.8 billion backlog also provides a decade of visibility into future cash flows.
Where is it headed?
Centrus is betting its entire future on scaling domestic enrichment to eliminate U.S. dependence on Russian nuclear fuel. Management is moving past the demonstration phase in Ohio and into commercial production of HALEU fuel. If this works, Centrus transforms from a trading company into the most critical infrastructure provider for the American nuclear renaissance.
Revenue is growing sharply as fuel prices rise, but the top line remains lumpy due to the timing of large delivery contracts. In the most recent quarter ending March 31, 2025, revenue jumped 67% to $73.1 million as the company benefitted from a 46% increase in the average price of enrichment services. This volatility is normal for a business that delivers fuel in large, infrequent batches rather than daily transactions.
Cash generation is thin because Centrus must plow almost all its profit back into the expensive equipment needed to build out its Ohio enrichment facility. While the company generated $80 million in net income for 2025, its free cash flow was only $30 million. This gap exists because the company is in a heavy investment phase, building the centrifuges and infrastructure required to scale up domestic production and move away from reselling foreign uranium.
The balance sheet carries a significant debt burden with a debt-to-equity ratio of 1.52x, reflecting the capital-intensive nature of building nuclear enrichment capacity. Centrus holds roughly $3.4 billion in market value but its ability to survive depends on its $3.8 billion backlog and its partnership with the U.S. government. For a company of this size, the balance sheet is stretched, making it highly sensitive to interest rates and government funding cycles.
Centrus is a high-potential business in a capital-heavy transition, and its financial health is entirely dependent on whether it can turn its massive backlog into cash.
The company's massive $3.8 billion backlog is growing and now extends all the way to 2040, providing nearly unrivaled visibility into future demand. This backlog grew by $100 million in just three months, proving that utilities are willing to sign long-term deals to lock in domestic fuel supplies. Centrus has successfully leveraged its status as the sole domestic HALEU producer to command higher prices.
The ban on Russian uranium imports creates a massive risk to the company's current business model of reselling fuel from the Russian provider Tenex. If Centrus cannot scale its own domestic production in Piketon fast enough to replace these Russian supplies, it could face a shortfall in its ability to fulfill existing customer contracts. Management is currently navigating a complex waiver process to keep some imports flowing while they build out the American cascades.
The global uranium enrichment market is roughly $6 billion today and is entering a period of forced reinvention as Western nations decouple from Russian supply. While the overall nuclear fuel industry grows slowly, the niche for HALEU fuel is expected to grow rapidly as next-generation reactors come online toward the end of the decade. The industry is shaped by extreme regulatory barriers and the fact that a handful of state-backed players control the entire global supply chain. Centrus stands as the only American-owned option in a market where energy security has become more important than the lowest price.
This market is brutally competitive among a tiny number of massive, state-linked entities because the cost to build new enrichment capacity is measured in billions of dollars. Barriers to entry are nearly absolute due to the decades required to secure Nuclear Regulatory Commission licenses and the specialized engineering talent needed to build centrifuges. Pricing power is high right now because supply is physically limited and Western utilities are desperate to find non-Russian sources.
Urenco and Orano are the primary threats because they already have the massive scale that Centrus is currently trying to build. Urenco is the most dangerous threat because it already operates enrichment facilities in the U.S. and is also expanding its capacity. While Tenex is being banned from the U.S., it still controls the cheapest global supply, which forces Centrus to compete on national security rather than on pure cost.
Centrus is currently gaining share in the high-assay fuel niche because it is the only company with the necessary license to produce it on American soil.
The primary source of protection is a regulatory moat that is almost impossible for a competitor to cross quickly. Centrus owns the only license to enrich uranium to the levels required by the next wave of nuclear reactors, effectively granting it a monopoly on the fuel of the future. The company also benefits from a deep partnership with the U.S. Department of Energy, which has spent hundreds of millions of dollars to co-fund the Ohio facility.
The company's thin 1.4% ROIC and 13.4% net margin show that it is still a capital-heavy business that has not yet reached efficient scale. The numbers prove that while Centrus has a regulatory monopoly, it is still in the expensive phase of building the infrastructure required to profit from it. The massive $3.8 billion backlog is the clearest evidence that customers recognize this advantage and are willing to commit capital to it for the long term.
The moat is strengthening as the U.S. government formalizes the ban on Russian uranium and provides the funding for Centrus to become the national champion.
Missed FY2026/27 EPS growth targets as company pivots toward domestic production.
Reinvesting $30M FCF into Ohio enrichment facility cascades rather than buybacks.
CEO Amir Vexler joined in Jan 2024; stake size not yet disclosed as significant.
Capital Allocation Track Record
Amir Vexler brings much-needed operational heritage from General Electric and Orano to lead the company's shift from a reseller to a high-tech manufacturer. While the team successfully met the Department of Energy's initial milestones for HALEU production, they are now entering a much harder phase of commercial scaling that requires massive capital raises. Their strategic judgment is currently being tested by the need to balance the legal ban on Russian uranium with the reality that their own production won't be fully ready for several years.
The primary governance risk is the company's extreme dependence on U.S. Department of Energy funding and federal policy, which can shift with each administration. Because Centrus is effectively a "national champion" for enrichment, its strategy is driven as much by government mandates as by market forces. If the political appetite for funding domestic uranium enrichment fades, the company has no credible backup plan for its capital-intensive expansion in Ohio.
Clearthesis wrote this report from 35 sources, including SEC filings, industry research, and recent news.
© 2026 Clearthesis.ai · Report generated on June 23, 2026
This is an AI-generated analysis for informational purposes only and does not constitute financial advice. Data and analysis may not reflect recent developments if viewed significantly after the generation date. Always conduct your own due diligence before making any investment decisions.
The market is bullish because Centrus serves as the only domestic provider of the specialized fuel required for next-generation nuclear reactors. The company has secured a 3.8 billion dollar contract backlog extending to 2040, effectively locking in future revenue as the United States shifts away from Russian uranium imports.
Skeptics think that relying on government contracts and specific policy mandates makes the business model fragile and prone to sudden shifts in political priority. The company remains vulnerable if lawmakers change course on nuclear energy subsidies or if the supply chain for next-generation reactors fails to scale as quickly as the contract backlog suggests.